Annual EBIT
-$28.04 M
+$6.05 M+17.74%
31 December 2023
Summary:
Tempest Therapeutics annual earnings before interest & taxes is currently -$28.04 million, with the most recent change of +$6.05 million (+17.74%) on 31 December 2023. During the last 3 years, it has fallen by -$8.83 million (-45.99%). TPST annual EBIT is now -45.99% below its all-time high of -$18.87 million.TPST EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.23 M
-$1.03 M-11.19%
30 September 2024
Summary:
Tempest Therapeutics quarterly earnings before interest & taxes is currently -$10.23 million, with the most recent change of -$1.03 million (-11.19%) on 30 September 2024. Over the past year, it has dropped by -$3.81 million (-59.47%). TPST quarterly EBIT is now -136.74% below its all-time high of -$4.32 million, reached on 31 December 2020.TPST Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$34.07 M
-$3.81 M-12.60%
30 September 2024
Summary:
Tempest Therapeutics TTM earnings before interest & taxes is currently -$34.07 million, with the most recent change of -$3.81 million (-12.60%) on 30 September 2024. Over the past year, it has dropped by -$4.47 million (-15.10%). TPST TTM EBIT is now -551.60% below its all-time high of -$5.23 million, reached on 30 June 2020.TPST TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.7% | -59.5% | -15.1% |
| 3 y3 years | -46.0% | -33.3% | -42.6% |
| 5 y5 years | - | - | - |
TPST EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -46.0% | +17.7% | -59.5% | at low | -42.6% | +0.1% |
| 5 y | 5 years | -46.0% | +17.7% | -136.7% | at low | -551.6% | +0.1% |
| alltime | all time | -46.0% | +17.7% | -136.7% | at low | -551.6% | +0.1% |
Tempest Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.23 M(+11.2%) | -$34.07 M(+12.6%) |
| June 2024 | - | -$9.20 M(+22.1%) | -$30.26 M(+7.0%) |
| Mar 2024 | - | -$7.54 M(+6.0%) | -$28.29 M(+0.9%) |
| Dec 2023 | -$28.04 M(-17.7%) | -$7.11 M(+10.9%) | -$28.04 M(-5.3%) |
| Sept 2023 | - | -$6.41 M(-11.3%) | -$29.60 M(-6.8%) |
| June 2023 | - | -$7.23 M(-0.9%) | -$31.75 M(-4.4%) |
| Mar 2023 | - | -$7.29 M(-15.9%) | -$33.23 M(-2.5%) |
| Dec 2022 | -$34.09 M | -$8.67 M(+1.3%) | -$34.09 M(+3.7%) |
| Sept 2022 | - | -$8.56 M(-1.7%) | -$32.86 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$8.70 M(+6.7%) | -$31.98 M(+6.4%) |
| Mar 2022 | - | -$8.16 M(+9.6%) | -$30.05 M(+11.2%) |
| Dec 2021 | -$27.02 M(+40.7%) | -$7.44 M(-3.0%) | -$27.02 M(+13.1%) |
| Sept 2021 | - | -$7.67 M(+13.1%) | -$23.90 M(+10.4%) |
| June 2021 | - | -$6.78 M(+32.4%) | -$21.66 M(+7.7%) |
| Mar 2021 | - | -$5.12 M(+18.6%) | -$20.10 M(+34.2%) |
| Dec 2020 | -$19.21 M | -$4.32 M(-20.5%) | -$14.98 M(+40.5%) |
| Sept 2020 | - | -$5.43 M(+3.9%) | -$10.66 M(+103.9%) |
| June 2020 | - | -$5.23 M | -$5.23 M |
FAQ
- What is Tempest Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tempest Therapeutics?
- What is Tempest Therapeutics annual EBIT year-on-year change?
- What is Tempest Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly EBIT year-on-year change?
- What is Tempest Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tempest Therapeutics?
- What is Tempest Therapeutics TTM EBIT year-on-year change?
What is Tempest Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TPST is -$28.04 M
What is the all time high annual EBIT for Tempest Therapeutics?
Tempest Therapeutics all-time high annual earnings before interest & taxes is -$18.87 M
What is Tempest Therapeutics annual EBIT year-on-year change?
Over the past year, TPST annual earnings before interest & taxes has changed by +$6.05 M (+17.74%)
What is Tempest Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TPST is -$10.23 M
What is the all time high quarterly EBIT for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly earnings before interest & taxes is -$4.32 M
What is Tempest Therapeutics quarterly EBIT year-on-year change?
Over the past year, TPST quarterly earnings before interest & taxes has changed by -$3.81 M (-59.47%)
What is Tempest Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TPST is -$34.07 M
What is the all time high TTM EBIT for Tempest Therapeutics?
Tempest Therapeutics all-time high TTM earnings before interest & taxes is -$5.23 M
What is Tempest Therapeutics TTM EBIT year-on-year change?
Over the past year, TPST TTM earnings before interest & taxes has changed by -$4.47 M (-15.10%)